180 related articles for article (PubMed ID: 32370741)
41. Local control in Ewing sarcoma of the chest wall: results of the EURO-EWING 99 trial.
Bedetti B; Wiebe K; Ranft A; Aebert H; Schmidt J; Jürgens H; Dirksen U
Ann Surg Oncol; 2015 Sep; 22(9):2853-9. PubMed ID: 26104542
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis.
Harshman LC; Xie W; Moreira RB; Bossé D; Ruiz Ares GJ; Sweeney CJ; Choueiri TK
Cancer; 2018 Mar; 124(5):925-933. PubMed ID: 29266178
[TBL] [Abstract][Full Text] [Related]
43. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy.
Shamberger RC; LaQuaglia MP; Gebhardt MC; Neff JR; Tarbell NJ; Marcus KC; Sailer SL; Womer RB; Miser JS; Dickman PS; Perlman EJ; Devidas M; Linda SB; Krailo MD; Grier HE; Granowetter L
Ann Surg; 2003 Oct; 238(4):563-7; discussion 567-8. PubMed ID: 14530727
[TBL] [Abstract][Full Text] [Related]
44. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria.
Burdach S; van Kaick B; Laws HJ; Ahrens S; Haase R; Körholz D; Pape H; Dunst J; Kahn T; Willers R; Engel B; Dirksen U; Kramm C; Nürnberger W; Heyll A; Ladenstein R; Gadner H; Jürgens H; Go el U
Ann Oncol; 2000 Nov; 11(11):1451-62. PubMed ID: 11142486
[TBL] [Abstract][Full Text] [Related]
45. Long-term follow-up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities.
Zeng C; Chen T; Wang J; Sun F; Huang J; Lu S; Zhu J; Zhang Y; Sun X; Zhen Z
Cancer Med; 2023 Apr; 12(8):9409-9419. PubMed ID: 36808251
[TBL] [Abstract][Full Text] [Related]
46. A Review of Ewing Sarcoma Treatment: Is it Still a Subject of Debate?
Kridis WB; Toumi N; Chaari H; Khanfir A; Ayadi K; Keskes H; Boudawara T; Daoud J; Frikha M
Rev Recent Clin Trials; 2017; 12(1):19-23. PubMed ID: 28117008
[TBL] [Abstract][Full Text] [Related]
47. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Pathologic Complete Response as a Surrogate for Long-Term Survival Outcomes in Triple-Negative Breast Cancer.
Huang M; O'Shaughnessy J; Zhao J; Haiderali A; Cortes J; Ramsey S; Briggs A; Karantza V; Aktan G; Qi CZ; Gu C; Xie J; Yuan M; Cook J; Untch M; Schmid P; Fasching PA
J Natl Compr Canc Netw; 2020 Aug; 18(8):1096-1104. PubMed ID: 32755985
[TBL] [Abstract][Full Text] [Related]
49. Renal Ewing tumors.
Zöllner S; Dirksen U; Jürgens H; Ranft A
Ann Oncol; 2013 Sep; 24(9):2455-61. PubMed ID: 23761687
[TBL] [Abstract][Full Text] [Related]
50. Treatment and outcome of patients with thoracic tumors of the Ewing sarcoma family: A report from the Cooperative Weichteilsarkom Studiengruppe CWS-81, -86, -91, -96, and -2002P trials.
Seitz G; Urla C; Sparber-Sauer M; Schuck A; Vokuhl C; Blank B; Klingebiel T; Kazanowska B; Fuchs J; Koscielniak E
Pediatr Blood Cancer; 2019 Mar; 66(3):e27537. PubMed ID: 30421578
[TBL] [Abstract][Full Text] [Related]
51. Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials.
Petrelli F; Tomasello G; Ghidini M; Lonati V; Passalacqua R; Barni S
HPB (Oxford); 2017 Nov; 19(11):944-950. PubMed ID: 28764887
[TBL] [Abstract][Full Text] [Related]
52. Time-to-event surrogate end-points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis.
Etekal T; Koehn K; Sborov DW; McClune B; Prasad V; Haslam A; Berger K; Booth C; Al Hadidi S; Abdallah AO; Goodman A; Mohyuddin GR
Br J Haematol; 2023 Mar; 200(5):587-594. PubMed ID: 36495317
[TBL] [Abstract][Full Text] [Related]
53. Developing a prognostic model for localized Ewing sarcoma family of tumors: A single institutional experience of 224 cases treated with uniform chemotherapy protocol.
Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Mohanti BK; Sharma MC; Vishnubhatla S; Bakhshi S
J Surg Oncol; 2015 May; 111(6):683-9. PubMed ID: 25557999
[TBL] [Abstract][Full Text] [Related]
54. Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points.
Lee L; Wang L; Crump M
Ann Oncol; 2011 Jun; 22(6):1392-1403. PubMed ID: 21266519
[TBL] [Abstract][Full Text] [Related]
55. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant.
Oberlin O; Rey A; Desfachelles AS; Philip T; Plantaz D; Schmitt C; Plouvier E; Lejars O; Rubie H; Terrier P; Michon J;
J Clin Oncol; 2006 Aug; 24(24):3997-4002. PubMed ID: 16921053
[TBL] [Abstract][Full Text] [Related]
56. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
[TBL] [Abstract][Full Text] [Related]
57. Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994.
Stiller CA; Passmore SJ; Kroll ME; Brownbill PA; Wallis JC; Craft AW
Br J Cancer; 2006 Jan; 94(1):22-9. PubMed ID: 16317433
[TBL] [Abstract][Full Text] [Related]
58. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
Michiels S; Le Maître A; Buyse M; Burzykowski T; Maillard E; Bogaerts J; Vermorken JB; Budach W; Pajak TF; Ang KK; Bourhis J; Pignon JP;
Lancet Oncol; 2009 Apr; 10(4):341-50. PubMed ID: 19246242
[TBL] [Abstract][Full Text] [Related]
59. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.
Paulussen M; Ahrens S; Dunst J; Winkelmann W; Exner GU; Kotz R; Amann G; Dockhorn-Dworniczak B; Harms D; Müller-Weihrich S; Welte K; Kornhuber B; Janka-Schaub G; Göbel U; Treuner J; Voûte PA; Zoubek A; Gadner H; Jürgens H
J Clin Oncol; 2001 Mar; 19(6):1818-29. PubMed ID: 11251014
[TBL] [Abstract][Full Text] [Related]
60. Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
Koch R; Haveman L; Ladenstein R; Brichard B; Jürgens H; Cyprova S; van den Berg H; Hassenpflug W; Raciborska A; Ek T; Baumhoer D; Egerer G; Kager L; Renard M; Hauser P; Burdach S; Bovee JVMG; Hong AM; Reichardt P; Kruseova J; Streitbürger A; Kühne T; Kessler T; Bernkopf M; Butterfaß-Bahloul T; Dhooge C; Bauer S; Kiss J; Paulussen M; Bonar F; Ranft A; Timmermann B; Rascon J; Vieth V; Kanerva J; Faldum A; Hartmann W; Hjorth L; Bhadri VA; Metzler M; Gelderblom H; Dirksen U
Clin Cancer Res; 2023 Dec; 29(24):5057-5068. PubMed ID: 37843857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]